{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T12:41:07Z","timestamp":1768653667665,"version":"3.49.0"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,1,16]]},"DOI":"10.1248\/bpb.b25-00585","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:09:24Z","timestamp":1768514964000},"page":"99-107","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Chronic Kidney Disease on the Onset of Sepsis: A Systematic Review"],"prefix":"10.1248","volume":"49","author":[{"given":"Sumika","family":"Osa","sequence":"first","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"},{"name":"Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1\u201320\u20131 Handayama, Chuo-Ku, Hamamatsu 431\u20133192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuka","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Kumamoto","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Komiya","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Satake","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1\u201320\u20131 Handayama, Chuo-Ku, Hamamatsu 431\u20133192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1\u201320\u20131 Handayama, Chuo-Ku, Hamamatsu 431\u20133192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Saran R, Robinson B, Abbott KC, <i>et al<\/i>. US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States. <i>Am. J. Kidney Dis.<\/i>, <b>71<\/b>, A7 (2018)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, Fukagawa M, Matsushita K, Praditpornsilpa K, Hooi LS, Iseki K, Lin MY, Stirnadel-Farrant HA, Jha V, Jun M. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. <i>BMJ Glob. Health<\/i>, <b>7<\/b>, e007525 (2022).","DOI":"10.1136\/bmjgh-2021-007525"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shih CJ, Chao PW, Ou SM, Chen YT. Long-term risk of cardiovascular events in patients with chronic kidney disease who have survived sepsis: a nationwide cohort study. <i>J. Am. Heart Assoc.<\/i>, <b>6<\/b>, e004613 (2017).","DOI":"10.1161\/JAHA.116.004613"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Aune D, Sun X, Nie J, Huang W, Liao B, Wang Y. Self-reported chronic kidney disease and the risk of all-cause and cause-specific mortality: outcome-wide association study of 54 causes of death in the National Health Interview Survey. <i>BMC Nephrol.<\/i>, <b>23<\/b>, 165 (2022).","DOI":"10.1186\/s12882-022-02771-1"},{"key":"5","unstructured":"5) Page MJ, McKenzie JE, Bossuyt PM, <i>et al<\/i>. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. <i>Rev. Panam. Salud Publica<\/i>, <b>46<\/b>, e112 (2022)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Higgins JPT, Morgan RL, Rooney AA, <i>et al<\/i>. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). <i>Environ. Int.<\/i>, <b>186<\/b>, 108602 (2024).","DOI":"10.1016\/j.envint.2024.108602"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Brown CR, Chen Z, Khurshan F, Kreibich M, Bavaria J, Groeneveld P, Desai N. Outcomes after thoracic endovascular aortic repair in patients with chronic kidney disease in the Medicare population. <i>J. Thorac. Cardiovasc. Surg.<\/i>, <b>159<\/b>, 402\u2013413 (2020).","DOI":"10.1016\/j.jtcvs.2019.01.118"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Cill\u00f3niz C, Domined\u00f2 C, Ielpo A, Ferrer M, Gabarr\u00fas A, Battaglini D, Bermejo-Martin J, Meli A, Garc\u00eda-Vidal C, Liapikou A, Singer M, Torres A. Risk and prognostic factors in very old patients with sepsis secondary to community-acquired pneumonia. <i>J. Clin. Med.<\/i>, <b>8<\/b>, 961 (2019).","DOI":"10.3390\/jcm8070961"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yang WS, Chang YC, Hsieh ML, Wang JL, Wu LC, Chang CH. Stratified risks of infection-related hospitalization in patients with chronic kidney disease\u2014a prospective cohort study. <i>Sci. Rep.<\/i>, <b>10<\/b>, 4475 (2020).","DOI":"10.1038\/s41598-020-61144-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, Howard G. Chronic medical conditions and risk of sepsis. <i>PLOS ONE<\/i>, <b>7<\/b>, e48307 (2012).","DOI":"10.1371\/journal.pone.0048307"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Aguiar-Ricardo I, Mateus H, Gon\u00e7alves-Pereira J. Hidden hospital mortality in patients with sepsis discharged from the intensive care unit. <i>Rev. Bras. Ter. Intensiva<\/i>, <b>31<\/b>, 122\u2013128 (2019).","DOI":"10.5935\/0103-507X.20190037"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Liyanarachi KV, Mohus RM, Rogne T, Gustad LT, \u00c5svold BO, Romundstad S, Sollig\u00e5rd E, Hallan S, Dam\u00e5s JK. Chronic kidney disease and risk of bloodstream infections and sepsis: a 17-year follow-up of the population-based Tr\u00f8ndelag Health Study in Norway. <i>Infection<\/i>, <b>52<\/b>, 1983\u20131993 (2024).","DOI":"10.1007\/s15010-024-02265-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Xu H, Gasparini A, Ishigami J, Mzayen K, Su G, Barany P, \u00c4rnl\u00f6v J, Lindholm B, Elinder CG, Matsushita K, Carrero JJ. eGFR and the risk of community-acquired infections. <i>Clin. J. Am. Soc. Nephrol.<\/i>, <b>12<\/b>, 1399\u20131408 (2017).","DOI":"10.2215\/CJN.00250117"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cherng YG, Chang CC, Yeh CC, Hsu YH, Chen TL, Liao CC. Adverse outcomes after non urological surgeries in patients with chronic kidney disease: a propensity-score-matched study. <i>Clin. Epidemiol.<\/i>, <b>11<\/b>, 707\u2013719 (2019).","DOI":"10.2147\/CLEP.S219140"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Cohen JS, Gu A, Wei C, Sobrio SA, Liu J, Abdel MP, Sculco PK. Preoperative estimated glomerular filtration rate is a marker for postoperative complications following revision total knee arthroplasty. <i>J. Arthroplasty<\/i>, <b>34<\/b>, 750\u2013754 (2019).","DOI":"10.1016\/j.arth.2018.12.005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Liao YC, Chang CC, Chen CY, Liu CC, Liao CC, Shih YRV, Lin CS. Preoperative renal insufficiency predicts postoperative adverse outcomes in a mixed surgical population: a retrospective matched cohort study using the NSQIP database. <i>Int. J. Surg.<\/i>, <b>109<\/b>, 752\u2013759 (2023).","DOI":"10.1097\/JS9.0000000000000278"},{"key":"17","unstructured":"17) Asghar A, Hashmi M, Rashid S, Khan FH. Incidence, outcome and risk factors for sepsis-a two year retrospective study at surgical intensive care unit of a teaching hospital in Pakistan. <i>J. Ayub. Med. Coll. Abbottabad.<\/i>, <b>28<\/b>, 79\u201383 (2016)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jaafar G, Hammarqvist F, Enochsson L, Sandblom G. Patient-related risk factors for postoperative infection after cholecystectomy. <i>World J. Surg.<\/i>, <b>41<\/b>, 2240\u20132244 (2017).","DOI":"10.1007\/s00268-017-4029-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Chen PY, Luo CW, Chen MH, Yang ML, Kuan YH. Epidemiological characteristics of postoperative sepsis. <i>Open Med.<\/i>, <b>14<\/b>, 928\u2013938 (2019).","DOI":"10.1515\/med-2019-0110"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Karamnov S, Brovman EY, Greco KJ, Urman RD. Risk factors and outcomes associated with sepsis after coronary artery bypass and open heart valve surgeries. <i>Semin. Cardiothorac. Vasc. Anesth.<\/i>, <b>22<\/b>, 359\u2013368 (2018).","DOI":"10.1177\/1089253218785362"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Locham S, Naazie I, Canner J, Siracuse J, Al-Nouri O, Malas M. Incidence and risk factors of sepsis in hemodialysis patients in the United States. <i>J. Vasc. Surg.<\/i>, <b>73<\/b>, 1016\u20131021.e3 (2021).","DOI":"10.1016\/j.jvs.2020.06.126"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Betjes MGH, Langerak AW, Van Der Spek A, De Wit EA, Litjens NHR. Premature aging of circulating T cells in patients with end-stage renal disease. <i>Kidney Int.<\/i>, <b>80<\/b>, 208\u2013217 (2011).","DOI":"10.1038\/ki.2011.110"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Espi M, Koppe L, Fouque D, Thaunat O. Chronic kidney disease-associated immune dysfunctions: impact of protein-bound uremic retention solutes on immune cells. <i>Toxins<\/i>, <b>12<\/b>, 300 (2020).","DOI":"10.3390\/toxins12050300"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR. CKD and risk of hospitalization and death with pneumonia. <i>Am. J. Kidney Dis.<\/i>, <b>54<\/b>, 24\u201332 (2009).","DOI":"10.1053\/j.ajkd.2009.04.005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Krueger KM, Ison MG, Ghossein C. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation. <i>Am. J. Kidney Dis.<\/i>, <b>75<\/b>, 417\u2013425 (2020).","DOI":"10.1053\/j.ajkd.2019.06.014"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Fernando SM, Rochwerg B, Seely AJE. Clinical implications of the third international consensus definitions for sepsis and septic shock (Sepsis-3). <i>CMAJ<\/i>, <b>190<\/b>, E1058\u2013E1059 (2018).","DOI":"10.1503\/cmaj.170149"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. <i>Chest<\/i>, <b>101<\/b>, 1644\u20131655 (1992).","DOI":"10.1378\/chest.101.6.1644"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Srzi\u0107 I, Nesek Adam V, Tunji\u0107 Pejak D. Sepsis definition: what\u2019s new in the treatment guidelines. <i>Acta Clin. Croat.<\/i>, <b>61<\/b> (Suppl. 1), 67\u201372 (2022).","DOI":"10.20471\/acc.2022.61.s1.11"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00585\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:28:09Z","timestamp":1768620489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00585\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00585","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"b25-00585"}}